MMedication Read More Amylyx endocrine drug succeeds in key study for low blood sugarAugust 23, 2026 Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected…
FFitness Read More An ‘Exercise Pill’ Just Cleared Its First Human TestAugust 20, 2026 Scientists might be inching closer to a breakthrough that some of us lazy bums would very much appreciate:…
MMedication Read More Enveda weight loss maintenance pill mimics exercise in early testsAugust 18, 2026 If you could design an oral treatment that limits appetite and mimics some effects of physical activity, you…
HHealth Read More Ultra-Processed Foods: Great Export for America, Bad News for the World’s HealthAugust 17, 2026 Ultra-processed foods (UPFs) have become a major concern in global public health, not only because they are linked…
HHealth Read More Self-guided online compassion therapy may improve quality of life in chronic illnessAugust 17, 2026 An eight-week online compassion program helped adults living with chronic conditions report better quality of life, suggesting that…
MMedication Read More UK approves its second weight-loss pill while EU access lags – POLITICOAugust 11, 2026 However, with the arrival of the first GLP-1 pill Wegovy (semaglutide) from Danish competitor Novo Nordisk — which…
FFitness Read More Once-weekly workout burns nearly as much fat as 3 workouts a weekAugust 3, 2026 One and done. The CDC and other health agencies recommend adults aim for at least 150 minutes of…
HHealth Read More Daily tomatoes lowered a key marker of liver fat in MASLD trialAugust 3, 2026 A six-week tomato-rich diet outperformed a tomato-free diet on an important marker of hepatic steatosis, pointing to a…
HHealthcare Read More Doctors And GLP-1 Users Respond To Trump’s ‘Fat Drugs’ CommentsAugust 1, 2026 The use of GLP-1s is skyrocketing throughout the world; 11% of American adults report taking the medications, up…
SScience Read More Ten-million-person study links semaglutide to lower COVID-19 mortalityJuly 31, 2026 After accounting for major health differences between semaglutide users and non-users, researchers identified a striking mortality association that…
MMedication Read More Loving your body in a world where weight stigma helps sell GLP-1 drugsJuly 30, 2026 Whether you’re living in a body that’s large or small, the rise of GLP-1 advertising and its use…
HHealthcare Read More Doctors And GLP-1 Users Respond To Trump’s ‘Fat Drugs’ CommentsJuly 28, 2026 The use of GLP-1s is skyrocketing throughout the world; 11% of American adults report taking the medications, up…